| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.065 | 0.7 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.065 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |